Late breaking trials of 2016 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
作者信息
Armstrong Ehrin J, Chhatriwalla Adnan K, Szerlip Molly, Swaminathan Rajesh V, Patel Rajan A G
机构信息
University of Colorado and Denver VA Medical Center, Denver, Colorado.
Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
出版信息
Catheter Cardiovasc Interv. 2017 May;89(6):1093-1099. doi: 10.1002/ccd.27004. Epub 2017 Mar 17.
PMID:28303672
Abstract
摘要
相似文献
1
Late breaking trials of 2016 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
Catheter Cardiovasc Interv. 2017 May;89(6):1093-1099. doi: 10.1002/ccd.27004. Epub 2017 Mar 17.
2
Late breaking trials of 2015 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
Catheter Cardiovasc Interv. 2016 May;87(6):1020-6. doi: 10.1002/ccd.26473. Epub 2016 Mar 7.
3
Late breaking trials of 2014 in structural heart disease and peripheral arterial disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
Catheter Cardiovasc Interv. 2015 Jul;86(1):80-4. doi: 10.1002/ccd.25941. Epub 2015 Apr 9.
4
Late breaking trials of 2016 in coronary artery disease: Commentary covering SCAI, ACC, TCT, EuroPCR, ESC, and AHA.
Catheter Cardiovasc Interv. 2017 May;89(6):1028-1034. doi: 10.1002/ccd.26940. Epub 2017 Mar 9.
5
Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013.关于欧洲心脏病学会（ESC）、心血管介入和血管治疗进展研讨会（VIVA）、经导管心血管治疗学术研讨会（TCT）、美国心脏协会（AHA，2012年秋季）以及美国心脏病学会（ACC，2013年）介入心脏病学最新突破性试验的评论
Catheter Cardiovasc Interv. 2014 May 1;83(6):936-43. doi: 10.1002/ccd.25301.
6
Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.
Catheter Cardiovasc Interv. 2016 Jun;87(7):1224-30. doi: 10.1002/ccd.26474. Epub 2016 Mar 4.
7
Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA.2014年冠状动脉疾病的最新试验：涵盖美国心脏病学会（ACC）、欧洲经皮心血管介入治疗大会（EuroPCR）、心血管造影和介入学会（SCAI）、经导管心血管治疗学术研讨会（TCT）、欧洲心脏病学会（ESC）及美国心脏协会（AHA）的评论
Catheter Cardiovasc Interv. 2015 Jul;86(1):73-9. doi: 10.1002/ccd.25942. Epub 2015 Apr 9.
8
Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013.对2013年欧洲心脏病学会（ESC）、心血管介入和血管治疗研讨会（VIVA）、经导管心血管治疗学术研讨会（TCT）及美国心脏协会（AHA）介入心脏病学领域重点最新试验的评论
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):95-103. doi: 10.1002/ccd.25635. Epub 2014 Oct 4.
9
ACCF/AHA update peripheral artery disease management guideline.美国心脏病学会/美国心脏协会更新外周动脉疾病管理指南。
Am Fam Physician. 2012 May 15;85(10):1000-1.
10
SCAI Is the voice of congenital and structural heart disease interventionalists.SCAI是先天性和结构性心脏病介入专家的代言人。
Catheter Cardiovasc Interv. 2016 Feb 15;87(3):349-50. doi: 10.1002/ccd.26446.
Zotero 插件